The report "Pyrogen Testing Market by Product
(Instruments, Services, Kits and Reagents), Application (Pharmaceutical &
Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot,
Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021"The global Pyrogen Testing market was valued at USD 610.2 Million in
2016. This market is expected to grow at a CAGR of 12.2% to reach USD 1086.3
Million in 2021.
Browse 74 market data Tables and 95 Figures spread through
173 Pages and in-depth TOC on "Pyrogen Testing
Market”
Early buyers will receive 10% customization on this
report.
Rapidly increasing pharmaceutical and biotechnology
industries and increasing number of new biologics products launched will be the
two most important growth drivers for this market during the forecast period.
For instance, the number of new biologics products launched annually witnessed
a strong upward trend between 2003 and 2013. The number of new products
launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has
increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong
pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology
industry, which is an important application of pyrogen testing products
Get The Sample Report For This Report@
The global pyrogen testing market is segmented on the basis
of applications, products, tests, and
geographies.
By application, the
market is divided into pharmaceuticals and biologicals manufacturing, medical
devices manufacturing, and other applications such as water purification, food
and beverages, cosmetics, and plastics and glass products. Of these, the
pharmaceuticals and biologicals manufacturing segment accounted for the largest
share of the global pyrogen testing market in 2016. The large share of this
segment can primarily be attributed to the rapid growth in pharmaceutical and
biotechnology industries.
The test segments
included in this report are in vitro pyrogen test, LAL (Limulus Amebocyte
Lysate) test, and Rabbit test. Of these the LAL (Limulus amebocyte lysate) test
holds the highest share. The large share of LAL test can primarily be
attributed to its advantages such as accuracy, speed, requirement of small
amount of the tested sample, more economical, and allows detection of lower
level of endotoxins, and flexibility in life science research. The LAL
test is further sub-segmented in to chromogenic tests, turbidimetric tests, and
gel clot tests.
Get The PDF Brochure For This Report@
The product segments
included in the report are kits and reagents, services, and Instruments. The
kits & reagents segment commanded the largest share of global pyrogen
testing market. The large share of this segment can mainly be attributed to
repeat purchase of kits and reagents as compared to instruments, and increasing
adoption of kit-based testing.
The geographic segments
included in this report are Asia, Europe, North America, and the Rest of the
World (RoW). North America is further segmented into the U.S. and Canada;
Europe is further segmented into France, Germany, Italy, Spain, the U.K., and
the Rest of Europe (RoE); Asia is further segmented into China, Japan, and
India, and the Rest of Asia; and the Rest of the World (RoW) is divided into
Africa, Pacific and Oceania, and South America, Central America, and the
Caribbean.
Major players in the pyrogen testing market include Associates of
Cape Cod, Inc. (U.S.) Charles River Laboratories International, Inc.
(U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza
Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc.
(U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc.
(China).
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’
revenues. Currently servicing 5000 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
No comments:
Post a Comment